ADVI Health is excited to announce the acquisition of Partnership for Health Analytic Research (PHAR), a leading global consultancy specializing in health technology assessment (HTA) and health economics and outcomes research (HEOR). PHAR is renowned for delivering impactful, data-driven insights…
SurGenTec, a leader in orthopedic and spine technology, is excited to announce that its proprietary B-MAN Bone Marrow Aspirate Kit has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The B-MAN Kit revolutionizes bone marrow aspiration by…
Techstars, Johns Hopkins University, and CareFirst BlueCross BlueShield (CareFirst) have announced a new collaboration to launch a healthcare accelerator program. This initiative aims to support early-stage entrepreneurs developing AI-driven solutions for improving care pathways. Techstars AI Health Baltimore, powered by…
Invenra Inc. is excited to announce that its innovative bispecific antibody, INV724, designed for the treatment of neuroblastoma, has received both Rare Pediatric Disease (RPDD) and Orphan Drug (ODD) Designations from the U.S. Food and Drug Administration (FDA). These designations…
VION Biosciences, a life science platform company specializing in specialty reagents for research, diagnostics, and drug discovery, has announced the acquisition of Echelon Biosciences, a Salt Lake City-based supplier known for its critical materials, including lipid-based excipients. This acquisition marks…
AISAP, a medical technology company focused on AI-powered Point-of-Care Assisted Diagnosis (POCAD™) solutions, has received 510(k) clearance from the U.S. FDA for its innovative AISAP CARDIO software platform. This cloud-based, AI-powered tool is designed for point-of-care ultrasound (POCUS) and integrates…
Pfizer Inc. and BioNTech SE announced that the U.S. FDA has approved their supplemental Biologics License Application for the Omicron KP.2-adapted COVID-19 vaccine (COMIRNATY®) for individuals aged 12 and older. The vaccine has also received emergency use authorization for individuals…
EMulate Therapeutics, Inc. has announced that the Open Journal of Biophysics (OJBIPHY) will publish its manuscript, titled “Magnetic Field Emulations of Small Inhibitor RNA: Effects on Implanted GL261 Tumors in C57BL/6 Immune Competent Mice.” This study supports independent findings recently…
Verint® (NASDAQ: VRNT), known as The CX Automation Company™, has announced that a leading healthcare provider is significantly expanding its deployment of the Verint Interaction Wrap Up Bot, increasing its use from 300 to 30,000 agents across its contact center.…
Innovo Therapeutics Inc. has announced promising results from its Phase 2 clinical trial for INV-001, an innovative treatment for post-thyroidectomy scars. The trial, conducted across four hospitals in Korea, including Severance Hospital in Seoul, involved 77 patients with thyroidectomy wounds…
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a leading provider of life science research and clinical diagnostics products, has announced the appointment of Jon DiVincenzo as President and Chief Operating Officer, starting September 9, 2024. DiVincenzo will succeed Andy Last,…
As the youth mental health crisis worsens, Akron Children’s is preparing to introduce a new tool to help teenagers manage anxiety and depression more effectively. Akron Children’s has partnered with Woebot Health to offer Woebot for Adolescents, an AI-powered mental…